(BRFS) BRF - Ratings and Ratios

Exchange: NYSE • Country: Brazil • Currency: USD • Type: Common Stock • ISIN: US10552T1079

BRFS: Poultry, Pork, Meat, Pasta, Margarine, Pet Food

BRF S.A., operating under the ticker symbol BRFS on the NYSE, is a prominent player in the food industry, specializing in poultry and pork production. Established in 1934 and headquartered in São Paulo, Brazil, BRF has evolved into a global entity, now a subsidiary of Marfrig Global Foods S.A. Their operations encompass the entire production chain, from raising and processing to manufacturing a diverse range of products.

The companys product portfolio is extensive, catering to various markets. They offer fresh meats, processed items like sausages and bacon, and frozen foods such as pizzas and ready-to-eat meals. Notably, BRF also ventures into plant-based products and halal-certified goods, addressing specific dietary needs and expanding their market reach, particularly in Islamic regions.

BRFs brand portfolio is equally impressive, with over 50 brands including Sadia, Perdigão, and Chester, among others. These brands serve a broad customer base, from supermarkets and wholesalers to restaurants and institutional buyers, ensuring wide market penetration and diversified revenue streams.

Financially, BRF presents an intriguing profile for investors. With a market capitalization of approximately $5.91 billion, the company boasts a P/E ratio of 9.23, lower than industry peers, suggesting potential undervaluation. The forward P/E of 4.81 indicates anticipated growth. The P/B ratio of 2.09 reflects a moderate premium on assets, while the P/S ratio of 0.10 underscores significant sales generation relative to market value.

BRFs strategic diversification into various markets and product lines, including halal and plant-based options, positions it to navigate market risks effectively. This approach, coupled with a strong brand presence, makes BRF a notable consideration for investors seeking exposure to the global food industry. For more information, visit their website at https://www.brf-global.com.

Additional Sources for BRFS Stock

BRFS Stock Overview

Market Cap in USD 5,682m
Sector Consumer Defensive
Industry Packaged Foods
GiC Sub-Industry Packaged Foods & Meats
IPO / Inception 2000-10-20

BRFS Stock Ratings

Growth 5y -25.3%
Fundamental 70.4%
Dividend 14.7%
Rel. Strength Industry 7.85
Analysts 3.5/5
Fair Price Momentum 3.04 USD
Fair Price DCF 91.41 USD

BRFS Dividends

Dividend Yield 12m 3.32%
Yield on Cost 5y 1.83%
Annual Growth 5y %
Payout Consistency 46.8%

BRFS Growth Ratios

Growth Correlation 3m -88.1%
Growth Correlation 12m 62.8%
Growth Correlation 5y -27.6%
CAGR 5y -12.44%
CAGR/Max DD 5y -0.15
Sharpe Ratio 12m 0.63
Alpha 11.05
Beta 0.58
Volatility 48.47%
Current Volume 1100.8k
Average Volume 20d 1794.8k
What is the price of BRFS stocks?
As of February 24, 2025, the stock is trading at USD 3.35 with a total of 1,100,804 shares traded.
Over the past week, the price has changed by -4.83%, over one month by -7.20%, over three months by -20.25% and over the past year by +22.60%.
Is BRF a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, BRF (NYSE:BRFS) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.41 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BRFS as of February 2025 is 3.04. This means that BRFS is currently overvalued and has a potential downside of -9.25%.
Is BRFS a buy, sell or hold?
BRF has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold BRFS.
  • Strong Buy: 0
  • Buy: 2
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for BRFS stock price target?
According to ValueRays Forecast Model, BRFS BRF will be worth about 3.4 in February 2026. The stock is currently trading at 3.35. This means that the stock has a potential upside of +0.9%.
Issuer Forecast Upside
Wallstreet Target Price 5.1 50.7%
Analysts Target Price 5.1 52.5%
ValueRay Target Price 3.4 0.9%